Etsuro Ito

Etsuro Ito

Auto-generated profile, based on publicly available information

Etsuro Ito

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KYKenichi Yoshida
Kenichi Yoshida
TTTsutomu Toki
Tsutomu Toki
YOYusuke Okuno
Yusuke Okuno
RKRika Kanezaki
Rika Kanezaki
YSYuichi Shiraishi
Yuichi Shiraishi
SOSeishi Ogawa
Seishi Ogawa

1 March 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AKAkira Kobayashi
Akira Kobayashi
EIEtsuro Ito
Etsuro Ito
TTTsutomu Toki
Tsutomu Toki
KKKeiji Kogame
Keiji Kogame
Shinichiro TakahashiShinichiro Takahashi
Shinichiro Takahashi
MYMasayuki Yamamoto
Masayuki Yamamoto
The NF-E2-binding sites or Mafrecognition elements (MARE) are essentialcis-acting elements in the regulatory regions of erythroid-specific genes recognized by the erythroid transcription factor NF-E2, composed of p45 and MafK. Recently, two p45-related factors Nrf1 and Nrf2 were isolated, and they are now collectively grouped as the Cap’n’ collar (CNC) family. CNC factors bind to MARE through heterodimer formation with small Maf proteins. We report here the identification and characterization of a novel CNC factor, Nrf3, encoding a predicted 73-kDa protein with a basic region-leucine zipper domain highly homologous to those of other CNC proteins. In vitro and in vivo analyses showed that Nrf3 can heterodimerize with MafK and that this complex binds to the MARE in the chicken β-globin enhancer and can activate transcription. Nrf3 mRNA is highly expressed in human placenta and B cell and monocyte lineage. Chromosomal localization of human Nrf3 is 7p14–15, which lies near the hoxA gene locus. As the genetic loci of p45, nrf1, andnrf2 have been mapped close to those ofhoxC, hoxB, and hoxD, respectively, the present study strongly argues for the idea that a single ancestral gene for the CNC family members may have been localized near the ancestral Hox cluster and have diverged to give rise to four closely related CNC factors through chromosome duplication.

1 April 1993 in Nature
Verified
Journal Article
Closed access
PDF file
EIEtsuro Ito
Etsuro Ito
TTTsutomu Toki
Tsutomu Toki
HIHajime Ishihara
Hajime Ishihara
HOHaruo Ohtani
Haruo Ohtani
LGLin Gu
Lin Gu
MYMasayuki Yamamoto
Masayuki Yamamoto

15 October 2003 in Blood
Verified
Journal Article
Closed access
PDF file
GXGang Xu
Gang Xu
MNMasumi Nagano
Masumi Nagano
RKRika Kanezaki
Rika Kanezaki
TTTsutomu Toki
Tsutomu Toki
YHYasuhide Hayashi
Yasuhide Hayashi
EIEtsuro Ito
Etsuro Ito
Transient myeloproliferative disorder (TMD) is a leukemoid reaction occurring occasionally in Down syndrome newborn infants. Acute megakaryocytic leukemia (AMKL) develops in approximately 20% to 30% of the cases with TMD. Recently, acquired mutations in the N-terminal activation domain of the GATA-1 gene, encoding the erythroid/megakaryocytic transcription factor GATA-1, have been reported in Down syndrome–related AMKL (DS-AMKL). To understand the multistep leukemogenesis in Down syndrome, GATA-1 mutations were investigated in patients with TMD. We show here that mutations in the GATA-1 gene were detected in 21 of 22 cases with TMD. Most of the mutations in TMD were located in the regions including exon 2 and were essentially identical to those observed in DS-AMKL. In the DS-AMKL cell line, MGS, which itself expresses only a truncated mutant of GATA-1, expression of full-length GATA-1 induced the differentiation toward the erythroid lineage. However, expression of the short form of GATA-1 did not induce erythroid differentiation. These results indicate that expression of GATA-1 with a defective N-terminal activation domain contributes to the expansion of TMD blast cells and that other genetic changes contribute to the development of AMKL in Down syndrome.

1 August 2019 in Cancer Cell
Verified
Journal Article
Closed access
MLMaurice Labuhn
Maurice Labuhn
KPKelly Perkins
Kelly Perkins
SMSören Matzk
Sören Matzk
LVLeila Varghese
Leila Varghese
CGCatherine Garnett
Catherine Garnett
JKJan-Henning Klusmann
Jan-Henning Klusmann

1 June 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AHAsuka Hira
Asuka Hira
KYKenichi Yoshida
Kenichi Yoshida
KSKoichi Sato
Koichi Sato
YOYusuke Okuno
Yusuke Okuno
YSYuichi Shiraishi
Yuichi Shiraishi
MYMiharu Yabe
Miharu Yabe